华夏恒生生科(03069)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03069 华夏恒生生科

已收盘 10-05 16:08:05

16.520

+0.140

+0.85%

最高16.520	最低16.220	成交量311.65万
今开16.450	昨收16.380	日振幅1.83%
总市值34.40亿	流通市值34.40亿	总股本2.08亿
成交额5,108万	换手率1.50%	流通股本2.08亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03069","market":"HK","secType":"STK","nameCN":"华夏恒生生科","latestPrice":16.52,"timestamp":1791187685005,"preClose":16.38,"halted":0,"volume":3116500,"delay":0,"changeRate":0.008547008547008583,"floatShares":208259213,"shares":208259213,"eps":0,"marketStatus":"已收盘","change":0.14,"latestTime":"10-05 16:08:05","open":16.45,"high":16.52,"low":16.22,"amount":51077775,"amplitude":0.018315,"askPrice":16.52,"askSize":2300,"bidPrice":16.44,"bidSize":8500,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791250200000},"marketStatusCode":5,"adr":0,"listingDate":1615996800000,"exchange":"SEHK","adjPreClose":16.38,"sharesOutstanding":237400000,"nav":16.3738,"aum":0,"dividendRate":0.003027,"bidAskSpread":0,"openAndCloseTimeList":[[1791163800000,1791172800000],[1791176400000,1791187200000]],"volumeRatio":0.716673,"lotSize":100,"spreadScale":3,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03069","defaultTab":"news","newsList":[{"id":"2672268507","title":"生物制药公司Agenus报告称，其BOT+BAL联合疗法在复发性卵巢癌患者中取得了48% 的估计三年生存率。","url":"https://stock-news.laohu8.com/highlight/detail?id=2672268507","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2672268507?lang=zh_cn&edition=full","pubTime":"2026-10-03 23:04","pubTimestamp":1791039869,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1610","MRNY","03069","BBP","IBBQ","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671564271","title":"科创板收盘播报：科创综指跌1.81% 生物制药股涨幅靠前","url":"https://stock-news.laohu8.com/highlight/detail?id=2671564271","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671564271?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:34","pubTimestamp":1790753669,"startTime":"0","endTime":"0","summary":"新华财经北京9月30日电（罗浩）科创50指数和科创综指30日早间分别以0.46%和0.56%的涨幅高开。两股指早盘期间整体呈震荡下行态势，午后窄幅整理，收盘时均大幅下跌。截至收盘，科创50指数报1530.01点，跌幅2.51%，成分股总成交额约719亿元，成交额较上一交易日小幅放量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11134,202609303887685155.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11134,202609303887685155.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["000680.SH","BK1610","MRNY","KSTR","IBBQ","03069","BBP","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671278515","title":"ETF异动 | AI制药赛道热度高涨 华夏恒生生科(03069)盘中涨超4% 华夏创新药(03525)午后涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671278515","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671278515?lang=zh_cn&edition=full","pubTime":"2026-09-30 13:44","pubTimestamp":1790747084,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，AI制药ETF延续近期涨势，截至发稿，华夏恒生生科涨3.58%，报16.8港元；华夏创新药涨2.95%，报10.48港元。消息面上，AI制药赛道热度高涨，AI4S正从“算力与模型”加速走向生物医药产业兑现。由OpenAI参投的生物科技初创公司Red Queen Bio计划于明年正式启动抗体药物的人体试验。同日，金斯瑞与礼来AI药物发现平台达成协作，公开资料显示，华夏恒生生科聚焦港股生物科技产业链，较大比例布局生命科学工具及服务企业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502543.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1152091754.HKD","LU0072913022.USD","LU0359201885.HKD","IE00B031HY20.USD","BK4550","BK1191","BK4585","01477","ARTY","LU1813983027.USD","FDN","BK1610","IE0008368742.USD","HK0000320223.HKD","LU1951186391.HKD","HK0000306685.HKD","IE0008369823.USD","IE00B5MMRT66.SGD","01548","AGIX","AIPO","01093","01276","HK0000165453.HKD","IE00B543WZ88.USD","KURE","LU2039709279.SGD","LU0359202008.SGD","VTHR","LU0067412154.USD","IE00BZ08YR35.GBP","LU1226287792.SGD","LU0501845795.SGD","IE00BZ08YS42.EUR","LU1152091168.USD","LU1226287875.USD","QTOC","BK1576","CHAT","LU1226287529.USD","LU0326950275.SGD","03525","IE00BZ08YT58.USD","SG9999004220.SGD","BK1521","LU1807302812.USD","LU1960683339.HKD","LU1993786604.SGD","LU0314109678.HKD","03069"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670401110","title":"股市必读：中国医药（600056）9月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2670401110","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670401110?lang=zh_cn&edition=full","pubTime":"2026-09-28 03:39","pubTimestamp":1790537950,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，中国医药报收于8.86元，下跌1.12%，换手率0.5%，成交量7.49万手，成交额6649.31万元。董秘最新回复投资者： 请问公司三季度是否会开业绩说明会，投资者急着与公司交流董秘： 您好！当日关注点交易信息汇总：9月24日主力资金净流入73.17万元，占总成交额1.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","600056","BK1610","BK0188","BK0082","BK0185","03069","BK0028","BK0250","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669635144","title":"中国医药：全面推进科技创新","url":"https://stock-news.laohu8.com/highlight/detail?id=2669635144","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669635144?lang=zh_cn&edition=full","pubTime":"2026-09-24 16:30","pubTimestamp":1790238636,"startTime":"0","endTime":"0","summary":"证券之星消息，中国医药(600056)09月24日在投资者关系平台上答复投资者关心的问题。投资者提问：联合湖北丽益、则正科技同步推进前沿创新药研发进程,请问这个创新药具体指的是？中国医药回复：您好！公司全面推进科技创新，在仿制药、改良型新药、创新药研究方面均有布局。则正医药建立了复杂注射剂技术、难溶性药物增溶递送技术、缓控释技术、药械组合技术、儿童药物研发创新技术、速释制剂技术、口服多肽技术以及原料合成技术八大核心自主研发平台；丽益科技专注于化学药物、中药及天然药物、药物新制剂、新工艺以及保健品研发。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400028204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03069","BK0175","BK0028","BK0082","BK0250","BK0188","600056","BK0010","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669484013","title":"佳兆业健康(00876)：中文股份简称将更改为“青海生物制药”","url":"https://stock-news.laohu8.com/highlight/detail?id=2669484013","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669484013?lang=zh_cn&edition=full","pubTime":"2026-09-23 22:44","pubTimestamp":1790174658,"startTime":"0","endTime":"0","summary":"更改公司名称后，于香港联交所买卖股份之英文股份简称将由“KAISA HEALTH”更改为“QH BIO PHARMA”，而中文股份简称将由“佳兆业健康”更改为“青海生物制药”，自2026年9月28日上午九时正起生效。本公司于香港联交所之股份代号保持不变，仍为“876”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1500165.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1239","BK1121","03069","BK1154","IBBQ","BK1230","MRNY","BBP","02954","BK1222","00876","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669610950","title":"中国医药：上半年度国际贸易板块实现主营业务收入24.59亿元，同比增长8.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669610950","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669610950?lang=zh_cn&edition=full","pubTime":"2026-09-23 16:30","pubTimestamp":1790152227,"startTime":"0","endTime":"0","summary":"证券之星消息，中国医药(600056)09月23日在投资者关系平台上答复投资者关心的问题。投资者提问：3月2日的中国医药保健品进出口商会交流，公司营收实现了较块增长，请问近年公司营收不断萎缩，这个较快增长指的是什么？既然实现了较快增长为什么二季度主业务板块基本都下降中国医药回复：您好！公司持续深耕重点海外市场，积极拓展进口内贸业务，上半年度国际贸易板块实现主营业务收入24.59亿元，同比增长8.60%。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300027774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600056","03069","BK0188","BK0185","BK0010","BK0250","BK0082","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669712999","title":"股市必读：中国医药（600056）9月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2669712999","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669712999?lang=zh_cn&edition=full","pubTime":"2026-09-23 01:46","pubTimestamp":1790099178,"startTime":"0","endTime":"0","summary":"截至2026年9月22日收盘，中国医药报收于9.05元，下跌0.55%，换手率0.54%，成交量8.14万手，成交额7383.58万元。董秘最新回复投资者： 近期看到公司获得了不少奖项，增强了公司的实力，公司业绩应该蒸蒸日上？投资者： 1.第24届世界制药原料中国展，则正医药携复杂制剂、儿药、口服缓控释等六大核心技术平台亮相，吸引众多新老客户、行业同仁驻足交流。当日关注点交易信息汇总：9月22日主力资金净流出767.29万元，占总成交额10.39%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300002327.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03069","BK0175","BK0010","BK0028","BK0250","600056","BK0082","BK0185","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669211201","title":"中国医药：公司坚持稳中求进，以科技创新为引领，加快转型升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2669211201","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669211201?lang=zh_cn&edition=full","pubTime":"2026-09-22 16:25","pubTimestamp":1790065519,"startTime":"0","endTime":"0","summary":"证券之星消息，中国医药(600056)09月22日在投资者关系平台上答复投资者关心的问题。投资者提问：近期看到有投资者质疑公司的奋斗目标和导向，请问公司如何打消投资者的质疑？中国医药回复：您好！公司坚持稳中求进，以科技创新为引领，加快转型升级。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200027418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600056","03069","BK0082","BK0175","BK0250","BK0028","BK0185","BK0188","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669056112","title":"中国医药：公司获得的各类奖项是行业及社会对公司的认可","url":"https://stock-news.laohu8.com/highlight/detail?id=2669056112","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669056112?lang=zh_cn&edition=full","pubTime":"2026-09-22 16:24","pubTimestamp":1790065463,"startTime":"0","endTime":"0","summary":"证券之星消息，中国医药(600056)09月22日在投资者关系平台上答复投资者关心的问题。投资者提问：近期看到公司获得了不少奖项，增强了公司的实力，公司业绩应该蒸蒸日上？请问公司近期的业绩如何？这些奖项有没有起到作用？中国医药回复：您好！公司获得的各类奖项是行业及社会对公司的认可，有助于提升公司品牌形象与行业影响力。公司将持续深耕主业，把品牌荣誉转化为经营动力。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200027330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","600056","BK0082","03069","BK0175","BK0028","BK0250","BK0185","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669130538","title":"野村：中国医药“十五五”规划突出创新与全球化 利好创新药企及CRDMO","url":"https://stock-news.laohu8.com/highlight/detail?id=2669130538","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669130538?lang=zh_cn&edition=full","pubTime":"2026-09-21 13:47","pubTimestamp":1789969625,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06978","BK1161","BK1574","03069"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668075449","title":"生物制药企业Electra美股上市：募资3.5亿美元 上半年亏4891万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2668075449","media":"雷递网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668075449?lang=zh_cn&edition=full","pubTime":"2026-09-20 10:32","pubTimestamp":1789871555,"startTime":"0","endTime":"0","summary":"生物制药企业Electra Therapeutics（股票代码：“ETRA”）日前在美国纳斯达克上市。","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260920/6392549715050864394546786.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260920/6392549715050864394546786.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n35194/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["03069","MRNX","IBBQ","IPOS","BBP","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668909545","title":"每周股票复盘：中国医药（600056）国贸板块H1营收24.59亿增8.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668909545","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668909545?lang=zh_cn&edition=full","pubTime":"2026-09-20 02:01","pubTimestamp":1789840869,"startTime":"0","endTime":"0","summary":"截至2026年9月18日收盘，中国医药报收于8.94元，较上周的8.91元上涨0.34%。本周，中国医药9月14日盘中最高价报8.99元。9月16日盘中最低价报8.8元。中国医药当前最新总市值133.73亿元，在医药商业板块市值排名7/32，在两市A股市值排名1424/5220。2026年上半年，公司国际贸易板块实现主营业务收入24.59亿元，同比增长8.60%。2026年上半年，公司深入践行乡村振兴战略，立足武川中药材资源，推动帮扶由“输血”转向长效“造血”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092000000499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03069","600056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667276603","title":"泰诺麦博：致力于成为一家全球化的创新生物制药企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2667276603","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667276603?lang=zh_cn&edition=full","pubTime":"2026-09-16 15:33","pubTimestamp":1789543997,"startTime":"0","endTime":"0","summary":"证券之星消息，泰诺麦博09月16日在投资者关系平台上答复投资者关心的问题。公司上市的两款核心产品均为‘全球首款’，充分印证了公司具备稀缺的FIC研发实力。在全球范围内，能够独立研发并成功上市两款FIC药物的企业屈指可数。公司致力于成为一家什么样的生物制药企业？","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600019428.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03069"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667467425","title":"广药集团李小军：中国医药企业出海，正从“产品输出”转向“生态协同”","url":"https://stock-news.laohu8.com/highlight/detail?id=2667467425","media":"凤凰网港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667467425?lang=zh_cn&edition=full","pubTime":"2026-09-16 12:07","pubTimestamp":1789531649,"startTime":"0","endTime":"0","summary":"广州医药集团党委书记、董事长李小军出席论坛，并发表主题演讲。李小军表示，当下全球健康产业格局正深刻重塑，中国医药企业的出海模式也正经历从产品输出向生态协同的深度迭代。过去讲出海，更多是把产品卖到全球。但现在，中国医药产业规模已稳居世界第二，在研新药管线约占全球三成，一线创新药研发正从跟跑走向并跑。只靠单品输出，已经不足以支撑真正的全球化，李小军给出的方向是生态出海。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://original.ifeng.com/c/8wSoePaEkdG","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0082","BK0175","BK0028","BK0010","BK0250","BK0188","BK0185","600056","03069"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667616875","title":"中国医药：9月11日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2667616875","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667616875?lang=zh_cn&edition=full","pubTime":"2026-09-15 13:07","pubTimestamp":1789448833,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年9月14日中国医药发布公告称公司于2026年9月11日召开业绩说明会。现在半年度业绩披露，营业收入只有170亿。2026年上半年，公司深入践行乡村振兴战略，立足武川中药材资源，推动帮扶由“输血”转向长效“造血”。中国医药主营业务：国际贸易业务,医药商业业务,医疗器械业务,医药工业业务,大健康和电商业务。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500018110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0082","BK0188","03069","BK0250","BK0028","BK0185","600056","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667554366","title":"ETF异动 | 华夏恒生生科(03069)涨超4% WCLC临床数据催化密集 机构看好创新药投资机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2667554366","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667554366?lang=zh_cn&edition=full","pubTime":"2026-09-14 15:17","pubTimestamp":1789370250,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，华夏恒生生科涨超4%。截至发稿，涨4.01%，报15.58港元，成交额6924.78万港元。本次WCLC会议上，中国新药表现亮眼，入选口头报告研究19项，小型口头报告研究45项，刷新记录。国金证券称，创新药企业扭亏节点到来，全年临床数据催化密集，叠加已BD出海管线海外临床进展顺利，看好创新药板块投资机会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495572.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","03069","159992","MEDX","BK4588","FDN","06978","LNGR","BK1161","BK4550","IBBQ","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667003455","title":"每周股票复盘：中国医药（600056）获业绩补偿款10,120.95万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667003455","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667003455?lang=zh_cn&edition=full","pubTime":"2026-09-13 03:00","pubTimestamp":1789239631,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，中国医药报收于8.91元，较上周的9.06元下跌1.66%。本周，中国医药9月8日盘中最高价报9.18元。本周关注点公司公告汇总：中国医药收到业绩补偿款本息合计10,120.95万元。公司公告汇总中国医药健康产业股份有限公司于2026年9月7日召开第十届董事会第7次会议，审议通过聘任张琳女士为公司董事会秘书，任期自董事会决议通过之日起至第十届董事会届满。案件判决已生效并进入执行阶段，涉案金额为13,940.41万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300000865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0082","03069","BK0250","BK0028","BK0010","600056","BK0175","BK0185","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666540384","title":"智飞生物：专一、专注、专业地在生物制药领域深耕","url":"https://stock-news.laohu8.com/highlight/detail?id=2666540384","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666540384?lang=zh_cn&edition=full","pubTime":"2026-09-11 16:57","pubTimestamp":1789117034,"startTime":"0","endTime":"0","summary":"证券之星消息，智飞生物(300122)09月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘，现在投资者很多都已经盼望智飞生物直接退市，本金早已经亏损完了，对公司发展更不抱有任何希望。公司针对这一现实情况，公司的市值管理计划是怎样实施的？效果怎样？请详细回答一下，谢谢。智飞生物回复：您好，公司专一、专注、专业地在生物制药领域深耕，聚焦生产经营稳健发展，持续开展产品创新，巩固核心竞争力；优化市场营销策略，提升商业推广效能；同时完善治理体系，强化全过程质量管理，为企业长远发展奠定坚实基础。感谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100036450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2148510915.USD","BK0196","LU2580892862.HKD","BK0239","LU1064130708.USD","03069","300122","BK0077","LU1064131003.USD","LU2580892789.USD","BK0046","BK0188","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666997515","title":"股市必读：派林生物新发布《北京市嘉源律师事务所关于派斯双林生物制药股份有限公司2026年第三次临时股东会的法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666997515","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666997515?lang=zh_cn&edition=full","pubTime":"2026-09-11 03:54","pubTimestamp":1789070077,"startTime":"0","endTime":"0","summary":"公司公告汇总北京市嘉源律师事务所关于派斯双林生物制药股份有限公司2026年第三次临时股东会的法律意见书北京市嘉源律师事务所对派斯双林生物制药股份有限公司2026年第三次临时股东会的召集、召开程序、出席会议人员资格、召集人资格、表决程序及表决结果进行了见证。会议召集、召开程序及表决结果合法有效，北京市嘉源律师事务所出具了法律意见书。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100011605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03069","BK0071","BK0239","000403"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0136},{"period":"1month","weight":0.0426},{"period":"3month","weight":0.1717},{"period":"6month","weight":0.0446},{"period":"1year","weight":-0.1034},{"period":"ytd","weight":0.1415}],"compareEarnings":[{"period":"1week","weight":-0.0219},{"period":"1month","weight":-0.0529},{"period":"3month","weight":0.0266},{"period":"6month","weight":-0.0456},{"period":"1year","weight":-0.1215},{"period":"ytd","weight":-0.0647}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"子基金的投资目标为提供紧贴指数表现的投资回报（未扣除费用及开支）。并不保证子基金能否达致其投资目标。子基金的指数经证监会事先批准及知会基金单位持有人后可更改。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.040155},{"month":2,"riseRate":0.4,"avgChangeRate":0.03003},{"month":3,"riseRate":0.2,"avgChangeRate":-0.029137},{"month":4,"riseRate":0.833333,"avgChangeRate":0.013346},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.016542},{"month":6,"riseRate":0.5,"avgChangeRate":0.022933},{"month":7,"riseRate":0.666667,"avgChangeRate":0.035744},{"month":8,"riseRate":0.5,"avgChangeRate":-0.011048},{"month":9,"riseRate":0.5,"avgChangeRate":0.034327},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.041824},{"month":11,"riseRate":0.6,"avgChangeRate":0.051035},{"month":12,"riseRate":0.2,"avgChangeRate":-0.056464}],"exchange":"SEHK","name":"华夏恒生生科","nameEN":"CAM HSBIOTECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华夏恒生生科(03069)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华夏恒生生科(03069)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华夏恒生生科,03069,华夏恒生生科股票,华夏恒生生科股票老虎,华夏恒生生科股票老虎国际,华夏恒生生科行情,华夏恒生生科股票行情,华夏恒生生科股价,华夏恒生生科股市,华夏恒生生科股票价格,华夏恒生生科股票交易,华夏恒生生科股票购买,华夏恒生生科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华夏恒生生科(03069)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华夏恒生生科(03069)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}